TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility

Diagnostic Cytopathology

Volumn 44, Issue 1, 2016, Pages 26-31

  Simms, Anthony ^a   Jacob, Reuben P ^a   Cohen, Cynthia ^a   Siddiqui, Momin T ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

fine needle aspiration; immunohistochemistry; papillary thyroid carcinoma; TROP 2

Indexed keywords

MEMBRANE PROTEIN; PROTEIN TROP 2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CARCINOGENESIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FINE NEEDLE ASPIRATION BIOPSY; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; IMMUNOHISTOCHEMISTRY; MEDULLARY CARCINOMA; ONCOCYTOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STAINING; THYROID CANCER; THYROID CARCINOMA; THYROID DISEASE; THYROID NODULE; TISSUE MICROARRAY; ADENOCARCINOMA, FOLLICULAR; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, NEUROENDOCRINE; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENETICS; PATHOLOGY; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS;

ADENOCARCINOMA, FOLLICULAR; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, NEUROENDOCRINE; CELL ADHESION MOLECULES; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; THYROID NODULE; TISSUE ARRAY ANALYSIS;

EID: 84949967722     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23382     Document Type: Article

References (35)

1. Cibas ES, Alexander EK, Benson CB, et al., Indications for thyroid FNA and pre-FNA requirements: A synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 2008; 36: 390-399.
2. Cibas ES, Ali SZ., The Bethesda system for reporting thyroid cytopathology. Thyroid 2009; 19: 1159-1165.
3. Sherman SI., Thyroid carcinoma. Lancet 2003; 361: 501-511
4. Piana S, Ragazzi M, Tallini G, et al., Papillary thyroid microcarcinoma with fatal outcome: Evidence of tumor progression in lymph node metastases: Report of 3 cases, with morphological and molecular analysis. Hum Pathol 2013; 44: 556-565.
5. Ko HM, Jhu IK, Yang SH, et al., Clinicopathologic analysis of fine needle aspiration cytology of the thyroid. A review of 1,613 cases and correlation with histopathologic diagnoses. Acta Cytol 2003; 47: 727-732.
6. Baloch ZW, LiVolsi VA., Fine-needle aspiration of the thyroid: Today and tomorrow. Best Pract Res Clin Endocrinol Metab 2008; 22: 929-939.
7. Pazaitou-Panayiotou K, Mygdakos N, Boglou K, Kiziridou A, Chrisoulidou A, Destouni C., The immunocytochemistry is a valuable tool in the diagnosis of papillary thyroid cancer in FNA's using liquid-based cytology. J Oncol 2010; 2010: 963926.
8. Ripani E, Sacchetti A, Corda D, Alberti S., Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 1998; 76: 671-676.
9. Schmitt AC, Cohen C, Siddiqui MT., Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: Diagnostic utility. Cancer Cytopathol 2010; 118: 196-202.
10. Asioli S, Maletta F, Pacchioni D, Lupo R, Bussolati G., Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Virchows Arch 2010; 457: 43-51.
11. Bartolazzi A, Orlandi F, Saggiorato E, et al., Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: A prospective multicenter study. Lancet Oncol 2008; 9: 543-549. doi: 10.1016/S1470- 2045(08)70132-3. Epub 2008 May 19.
12. Chandan VS, Faquin WC, Wilbur DC, Khurana KK., The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma. Cancer 2006; 108: 331-336.
13. Khurana KK, Truong LD, LiVolsi VA, Baloch ZW., Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch Pathol LabMed 2003; 127: 579-583.
14. Pusztaszeri MP, Sadow PM, Faquin WC., CD117: A novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies. Cancer Cytopathol 2014; 122: 596-603. doi: 10.1002/cncy.21437.
15. Asa SL., The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid. Endocr Pathol 2005; 16: 295-309.
16. Scognamiglo T, Hyjek E, Kao J, Chen YT., Diagnostic usefulness of HBME-1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol 2006; 126: 700-708.
17. Nasr MR, Mukhopadhyay S, Zhang S, Katzanstein AL., Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME-1 combined with CK19 immunostaining. Mod Pathol 2006; 19: 1631-1637.
18. Saleh HA, Feng J, Tabassum F, Al-Zohaili O, Husain M, Giorgadze T., Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy. Cytojournal 2009; 6: 18.
19. Rossi ED, Raffaelli M, Mule A, et al., Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology 2006; 48: 795-800.
20. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL., Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001; 14: 338-342.
21. Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, de la Chapelle A, Kloos RT., Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 2005; 18: 48-57.
22. Bartolazzi A, Gasbarri A, Papotti M, et al., Application of an immunodiagnostic method for improving pre-operative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644-1650.
23. Orlandi F, Saggiorato E, Pivano G, et al., Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998; 58: 3015-3020.
24. Mehrotra P, Okpokam A, Bouhaidar R, et al., Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2004; 45: 493-500.
25. Park YJ, Kwak SH, Kim DC, et al., Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci 2007; 22: 621-628.
26. Asioli S, Bussolati G., Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions. Histopathology 2009; 54: 571-579.
27. Lacroix L, Mian C, Barrier T, et al., PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues. Eur J Endocrinol 2004; 151: 367-374.
28. Fong D, Moser P, Krammel C, et al., High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 2008; 99: 1290-1295.
29. Mühlmann G, Spizzo G, Gostner J, et al., TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 2009; 62: 152-158.
30. Fong D, Spizzo G, Gostner JM, et al., TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 2008; 21: 186-191.
31. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M., Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 2006; 12: 3057-3063.
32. Fang YJ, Lu ZH, Wang GQ, et al., Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 2009; 24: 875-884.
33. Bignotti E, Todeschini P, Calza S, et al., Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 2010; 46: 944-953.
34. Trerotola M, Cantanelli P, Guerra E, et al., Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 2013; 32: 222-233.
35. Addati T, Achille G, Centrone M, et al., TROP-2 expression in papillary thyroid cancer: A preliminary cyto- histological study. Cytopathology 2014 2015; 26: 303-311.